ShanX Medtech secures EUR24 M to bring ultra-rapid antimicrobial susceptibility diagnostics to market

ShanX Medtech B.V. announces the successful closing of a total of EUR 24 million in financing to accelerate the development...

EUR8,85 M Contract fuels ShanX MedTech–led advances in point-of-care AST

ShanX MedTech has been awarded an EU4Health contract to lead a European joint tender developing a rapid point-of-care (POC) antimicrobial...

ShanX Medtech is going on Dutch national TV!

Tune in on SBS6’s ‘Bouwen aan de Toekomst’ - in English: ‘Builders of the future’ with a special feature on...

AMR-Global highlights SXM as a flagship of scientific partnership to fight AMR

“Bridging public-private sector efforts to address AMR have borne many fruits, with ShanX’s new testing device being one of our...